(Q40433328)

20 September 2017

1 reference

title

Tumor heterogeneity and immunotherapy of cancer (English)

1 reference

20 September 2017

1 reference

Fleuren GJ

1

1 reference

20 September 2017

Gorter A

2

1 reference

20 September 2017

Kuppen PJ

3

1 reference

20 September 2017

Litvinov S

4

1 reference

20 September 2017

Warnaar SO

5

1 reference

20 September 2017

1 June 1995

1 reference

20 September 2017

Immunological Reviews

1 reference

20 September 2017

145

1 reference

20 September 2017

91-122

1 reference

Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Post-thymectomy autoimmunity: abnormal T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The tumor marker CA 125 is a common constituent of normal cervical mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Somatic genetic changes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Nuclear structure and the three-dimensional organization of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Cell membrane-associated mucins and their adhesion-modulating property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The B7 and CD28 receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

T cell co-stimulation and in vivo tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

21 January 2018

The invasive phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Autoradiographic evaluation of monoclonal antibodies' access to melanoma-associated antigens in melanoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

T-cell immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

E-cadherin expression in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Role of NK cells in tumour growth and metastasis in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumours).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Expression of major histocompatibility complex (MHC) antigens and their loss on culture in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

How does the extracellular matrix direct gene expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

From laminin to lamin: regulation of tissue-specific gene expression by the ECM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Cell interactions in alveolar macrophage-mediated suppression of the immune response: an unusual suppressor pathway involving a population of T-cells that express Lyt-1, L3T4, and I-J

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Carcinoembryonic antigen in primary and metastatic ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Nuclear DNA content of medullary thyroid carcinoma in a large family with the MEN-2A syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Tumor markers for ovarian cancer. A comparative immunohistochemical and immunocytochemical study of two commercial monoclonal antibodies (OV632 and OC125)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies: OV-TL 3/CD3 and OC/TR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00078.X

10.1111/J.1600-065X.1995.TB00078.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference